Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


febrero 2016

CIRCULATION: CARDIOVASCULAR INTERVENTIONS. Myocardial Infarction. Comparison of Immediate With Delayed Stenting Using the Minimalist Immediate Mechanical Intervention Approach in Acute ST-Segment–Elevation Myocardial Infarction. The MIMI Study

Loic Belle, MD, Pascal Motreff, MD, PhD, Lionel Mangin, MD, Grégoire Rangé, MD, Xavier Marcaggi, MD, Antoine Marie, MD, Nadine Ferrier, MD, Olivier Dubreuil, MD, Gilles Zemour, MD, Géraud Souteyrand, MD, Christophe Caussin, MD, Nicolas Amabile, MD, PhD, Karl Isaaz, MD, PhD, Raphael Dauphin, MD, René Koning, MD, Christophe Robin, MD, Benjamin Faurie, MD, Laurent Bonello, MD, Stanislas Champin, MD, Cédric Delhaye, MD, François Cuilleret, MD, Nathan Mewton, MD, PhD, Céline Genty, MSc, Magalie Viallon, PhD, Jean Luc Bosson, MD, PhD, Pierre Croisille, MD, PhD, on behalf of the MIMI Investigators*

Background: Delayed stent implantation after restoration of normal epicardial flow by a minimalist immediate mechanical intervention aims to decrease the rate of distal embolization and impaired myocardial reperfusion after percutaneous coronary intervention. We sought to confirm whether a delayed stenting (DS) approach (24–48 hours) improves myocardial reperfusion, versus immediate stenting, in patients with acute ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary intervention.

18 marzo 2016

CIRCULATION. Interventional Cardiology. Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study

Ian T. Meredith, MBBS, PhD; Jean-François Tanguay, MD; Dean J. Kereiakes, MD; Donald E. Cutlip, MD; Robert W. Yeh, MD, MSc; Kirk N. Garratt, MD; David P. Lee, MD; P. Gabriel Steg, MD; W. Douglas Weaver, MD; David R. Holmes Jr., MD; Ralph G. Brindis, MD, MPH; Jaroslaw Trebacz, MD; Joseph M. Massaro, PhD; Wen-Hua Hsieh, PhD; Laura Mauri, MD, MSc; on behalf of the DAPT Study Investigators

Background: Patients with diabetes mellitus (DM) are at high risk for recurrent ischemic events after coronary stenting. We assessed the effects of continued thienopyridine among patients with DM participating in the Dual Antiplatelet Therapy (DAPT) Study as a prespecified analysis.

15 marzo 2016

CIRCULATION. Coronary Heart Disease. Coronary Collateral Growth Induced by Physical Exercise. Results of the Impact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease (EXCITE) Trial

Sven Möbius-Winkler, MD*; Madlen Uhlemann, MD*; Volker Adams, PhD; Marcus Sandri, MD; Sandra Erbs, MD; Karsten Lenk, MD; Norman Mangner, MD; Ulrike Mueller, MD; Jennifer Adam, MA; Martin Grunze, MD; Susanne Brunner, MD; Thomas Hilberg, MD, PhD; Meinhard Mende, PhD; Axel P. Linke, MD; Gerhard Schuler, MD

Background: A well-developed coronary collateral circulation provides a potential source of blood supply in coronary artery disease. However, the prognostic importance and functional relevance of coronary collaterals is controversial with the association between exercise training and collateral growth still unclear.

16 enero 2015

CIRCULATION. Epidemiology and Prevention. Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis

Kevin E. Chan, MD, MSc; Elazer R. Edelman, MD, PhD; Julia B. Wenger, MPH; Ravi I. Thadhani, MD, MPH; Franklin W. Maddux, MD

Background: Dabigatran and rivaroxaban are new oral anticoagulants that are eliminated through the kidneys. Their use in dialysis patients is discouraged because these drugs can bioaccumulate to precipitate inadvertent bleeding. We wanted to determine whether prescription of dabigatran or rivaroxaban was occurring in the dialysis population and whether these practices were safe.

01 marzo 2016

THE BRITISH JOURNAL OF CARDIOLOGY. Advances in transcatheter options in the management of mitral valve disease

Mamta H Buch

Current transcatheter mitral valve techniques are at the beginning of an era of innovation before their full potential is realised. The broadening of available options for mitral regurgitation (MR) reduction is welcome and transcatheter mitral valve interventions provide complementary strategies in the drive for more safe and effective therapies for patients. In this article, the evidence and indications for MitraClip® are reviewed.

01 abril 2016

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Late complete atrioventricular block after closure of an atrial septal defect with a gore septal occluder (GSO™)

Sven Dittrich MD1,*, Matthias Sigler MD2 andHelga Priessmann MD1

Abstract: Temporary intermittent complete heart block (CHB) occurred the day after interventional closure of an ASD with a 30 mm Gore Septal Occluder (GSO™) in a 2 years and 11-month-old female. CHB disappeared without further treatment and stable sinus rhythm recovered within 3 days. Only short episodes of 2nd degree AV-block (Wenckebach periodicity) at rare intervals were documented in Holter-monitors the following 2 months. Eleven months after device implantation the patient suffered from long lasting episodes of CHB. Surgical removal of the device resulted in incomplete recovery of AV-conduction. Histopathological work-up of the explanted GSO showed complete endothelialization of the device and regular scar formation. One year after surgery, the child had sinus rhythm during daytime but needed VVI-pacing while sleeping. Young age, inferior localization of the defect, and use of a large device have been individual risk factors for CHB in this patient. Clinical course and histologic findings indicate that mechanical compression was the only cause for CHB. The cumulative number of reports of CHB after use of different ASD-devices supports the recommendation to postpone the intervention in asymptomatic patients to preschool-age. Early removal of a pushing device may increase the chance of complete recovery from CHB. © 2015 Wiley Periodicals, Inc.

20 abril 2016

JOURNAL OF THE AMERICAN HEART ASSOCIATION. Interventional Cardiology. Functional Versus Anatomic Assessment of Myocardial Bridging by Intravascular Ultrasound: Impact of Arterial Compression on Proximal Atherosclerotic Plaque

Ryotaro Yamada, MD, PhD1; Jennifer A. Tremmel, MD, MS1; Shigemitsu Tanaka, MD1; Shin Lin, MD, PhD, MHS1; Yuhei Kobayashi, MD1; M. Brooke Hollak, RN, BAHSA1; Paul G. Yock, MD1; Peter J. Fitzgerald, MD, PhD1; Ingela Schnittger, MD1; Yasuhiro Honda, MD*,1

Background: The presence of a myocardial bridge (MB) has been shown to promote atherosclerotic plaque formation proximal to the MB, presumably because of hemodynamic disturbances provoked by retrograde blood flow toward this segment in cardiac systole. We aimed to determine the anatomic and functional properties of an MB related to the extent of atherosclerosis assessed by intravascular ultrasound.

22 abril 2016

JOURNAL OF THE AMERICAN HEART ASSOCIATION. Interventional Cardiology. Costs and Benefits Associated With Transradial Versus Transfemoral Percutaneous Coronary Intervention in China

Chen Jin, MD, MSc1; Wei Li, PhD*,1; Shu‐Bin Qiao, MD, PhD1; Jin‐Gang Yang, MD, PhD1; Yang Wang, MSc1; Pei‐Yuan He, MD, PhD1; Xin‐Ran Tang, BS1; Qiu‐Ting Dong, MD, PhD1; Xiang‐Dong Li, MD, PhD1; Hong‐Bing Yan, MD, PhD1; Yong‐Jian Wu, MD, PhD1; Ji‐Lin Chen, MD1; Run‐Lin Gao, MD1; Jin‐Qing Yuan, MD, PhD1; Ke‐Fei Dou, MD, PhD1; Bo Xu, BS1; Wei Zhao, BS1; Xue Zhang, BS1; Ying Xian, MD, PhD2; Yue‐Jin Yang, MD, PhD*,1

Backgroun: Transradial percutaneous coronary intervention (PCI) has been increasingly adopted in clinical practice, given its potential advantages over transfemoral intervention; however, the impact of different access strategies on costs and clinical outcomes remains poorly defined, especially in the developing world.

08 febrero 2016

JOURNAL OF THE AMERICAN HEART ASSOCIATION. Imaging. Impact of Prosthesis‐Patient Mismatch on Left Ventricular Myocardial Mechanics After Transcatheter Aortic Valve Replacement

Frédéric Poulin, MD, MSc1,3; Teerapat Yingchoncharoen, MD2; William M. Wilson, MBBS1; Eric M. Horlick, MDCM1; Philippe Généreux, MD3; E. Murat Tuzcu, MD2; William Stewart, MD2; Mark D. Osten, MD1; Anna Woo, MD, SM1; Paaladinesh Thavendiranathan, MD, MSc*,1

Backgroun: The aim of this study was to compare left ventricular (LV) remodeling using myocardial strain between patients with severe aortic stenosis (AS) treated with transcatheter aortic valve replacement (TAVR) with and without prosthesis‐patient mismatch (PPM).

23 febrero 2016

JOURNAL OF THE AMERICAN HEART ASSOCIATION. Imaging. Impairment of Coronary Flow Reserve Evaluated by Phase Contrast Cine‐Magnetic Resonance Imaging in Patients With Heart Failure With Preserved Ejection Fraction

Shingo Kato, MD, PhD*,1,†; Naka Saito, MT2,†; Hidekuni Kirigaya, MD2; Daiki Gyotoku, MD2; Naoki Iinuma, MD2; Yuka Kusakawa, MD2; Kohei Iguchi, MD2; Tatsuya Nakachi, MD2; Kazuki Fukui, MD2; Masaaki Futaki, MD3; Tae Iwasawa, MD3; Kazuo Kimura, MD4; Satoshi Umemura, MD, PhD5

Background: Phase contrast (PC) cine‐magnetic resonance imaging (MRI) of the coronary sinus allows for noninvasive evaluation of coronary flow reserve (CFR), which is an index of left ventricular microvascular function. The objective of this study was to investigate coronary flow reserve in patients with heart failure with preserved ejection fraction (HFpEF).

15 marzo 2016

JOURNAL OF THE AMERICAN HEART ASSOCIATION. Interventional Cardiology. Metabolite Profiles Predict Acute Kidney Injury and Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement

Sammy Elmariah, MD, MPH1,2,5; Laurie A. Farrell, RN1,2; Maureen Daher, RN1; Xu Shi, PhD1,2; Michelle J. Keyes, PhD1,2; Carolyn H. Cain, RN1; Eugene Pomerantsev, MD, PhD1; Gus J. Vlahakes, MD3; Ignacio Inglessis, MD1; Jonathan J. Passeri, MD1; Igor F. Palacios, MD1; Caroline S. Fox, MD, MPH6,7,8; Eugene P. Rhee, MD2,4,†; Robert E. Gerszten, MD*,1,2,†

Background: Acute kidney injury (AKI) occurs commonly after transcatheter aortic valve replacement (TAVR) and is associated with markedly increased postoperative mortality. We previously identified plasma metabolites predictive of incident chronic kidney disease, but whether metabolite profiles can identify those at risk of AKI is unknown.

18 marzo 2016

JOURNAL OF THE AMERICAN HEART ASSOCIATION. Interventional Cardiology. Comparison of Long‐Term Clinical Outcomes of Lesions Exhibiting Focal and Segmental Peri‐Stent Contrast Staining

Takahiro Tokuda, MD*,1; Masahiro Yamawaki, MD, PhD1; Mitsuyohi Takahara, MD2; Shinsuke Mori, MD1; Kenji Makino, MD1; Yosuke Honda, MD1; Hiroya Takafuji, MD1; Takuro Takama, MD1; Masakazu Tsutsumi, MD1; Yasunari Sakamoto, MD1; Hideyuki Takimura, MD1; Norihiro Kobayashi, MD1; Motoharu Araki, MD1; Keisuke Hirano, MD1; Yoshiaki Ito, MD1

Background: Peri‐stent contrast staining (PSS) after metallic drug‐eluting stent deployment is associated with target lesion revascularization and very late stent thrombosis. However, the type of PSS that influences the clinical outcomes is unknown. Therefore, we aimed to reveal which PSS type was influencing clinical outcomes.

25 enero 2016

JOURNAL OF THE AMERICAN HEART ASSOCIATION. Interventional Cardiology. Radial Artery Occlusion After Transradial Interventions: A Systematic Review and Meta‐Analysis

Muhammad Rashid, MBBS1,2; Chun Shing Kwok, MBBS2; Samir Pancholy, MD3; Sanjay Chugh, MD4; Sasko A. Kedev, MD, PhD5; Ivo Bernat, MD6; Karim Ratib, MBChB7; Adrian Large, MD7; Doug Fraser, MBBChir8; James Nolan, MBChB7; Mamas A. Mamas, BMBCh, PhD2,7,9

Background: Radial artery occlusion (RAO) may occur posttransradial intervention and limits the radial artery as a future access site, thus precluding its use as an arterial conduit. In this study, we investigate the incidence and factors influencing the RAO in the current literature.

25 enero 2016

JOURNAL OF THE AMERICAN HEART ASSOCIATION. Interventional Cardiology. Comprehensive Assessment of Coronary Plaque Progression With Advanced Intravascular Imaging, Physiological Measures, and Wall Shear Stress: A Pilot Double‐Blinded Randomized Controlled Clinical Trial of Nebivolol Versus Atenolol in Nonobstructive Coronary Artery Disease

Olivia Y. Hung, MD, PhD1; David Molony, PhD3; Michel T. Corban, MD1; Emad Rasoul‐Arzrumly, MD1; Charles Maynard, PhD4; Parham Eshtehardi, MD1; Saurabh Dhawan, MD1; Lucas H. Timmins, PhD1,3; Marina Piccinelli, PhD5; Sung Gyun Ahn, MD, PhD1,2; Bill D. Gogas, MD, PhD1; Michael C. McDaniel, MD1; Arshed A. Quyyumi, MD1; Don P. Giddens, PhD3; Habib Samady, MD1

Background: We hypothesized that nebivolol, a β‐blocker with nitric oxide–mediated activity, compared with atenolol, a β‐blocker without such activity, would decrease oxidative stress and improve the effects of endothelial dysfunction and wall shear stress (WSS), thereby reducing atherosclerosis progression and vulnerability in patients with nonobstructive coronary artery disease.

01 mayo 2015

JACC: CARDIOVASCULAR INTERVENTIONS. Diagnostic Accuracy of Baseline Distal-to-Aortic Pressure Ratio to Assess Coronary Stenosis Severity. A Post-Hoc Analysis of the ADVISE II Study

Mauro Echavarría-Pinto, MD; Tim P. van de Hoef, MD; Hector M. Garcia-Garcia, MD, PhD; Ton de Vries, MA; Patrick W. Serruys, MD, PhD; Habib Samady, MD; Jan J. Piek, MD, PhD; Amir Lerman, MD; Javier Escaned, MD, PhD

The demonstration that coronary revascularization on the basis of functional rather than anatomic stenosis assessment results in better patient outcomes has stimulated the interest in fractional flow reserve (FFR) and other physiological indexes (1). The instantaneous wave-free ratio (iFR), introduced in late 2011, was developed to facilitate the functional assessment of coronary stenoses by obviating the need for vasodilator drugs (2).

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.